Factors Associated with the Selection of First-line Bevacizumab plus Chemotherapy and Clinical Response in HER2-negative Metastatic Breast Cancer: ONCOSUR AVALOX Study

1. Manso, L.
2. Palomo, A.G.
3. Pérez Carrión, R.
4. Cassinello, J.
5. Gallegos Sancho, I.
6. Chacón López-Muñiz, I.
7. Olier, C.
8. Fernández-Aramburo, A.
9. Llorca, C.
10. González, X.
11. Llorente, R.
12. Torregrosa, D.
13. Álvarez, I.
14. Gálve, E.
15. Bueno, C.
16. Garau, I.
17. García, M.J.
18. González-Santiago, S.
19. Ballesteros, A.I.
20. Blanco, E.
21. Galán, A.
22. González, S.
23. Perelló, A.
24. Cortés-Funes, H.
25. Grávalos, C.